Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Phibro Animal Health
PAHC
Phibro Animal Health
Global Protein Demand And Food Safety Will Unlock Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
01 Jun 25
Updated
20 Aug 25
1
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$35.00
7.3% undervalued
intrinsic discount
20 Aug
US$32.46
Loading
1Y
55.0%
7D
5.8%
Author's Valuation
US$35.0
7.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$35.0
7.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
2b
2014
2017
2020
2023
2025
2026
2028
Revenue US$1.5b
Earnings US$94.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.40%
Pharma revenue growth rate
0.58%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$94.69m
Earnings '28
x
18.00x
PE Ratio '28
=
US$1.70b
Market Cap '28
US$1.70b
Market Cap '28
/
40.62m
No. shares '28
=
US$41.95
Share Price '28
US$41.95
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$34.46
Fair Value '25